Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Zogenix and Battelle Extend DosePro Co-Marketing Partnership

By Pharmaceutical Processing | March 27, 2013

 

Zogenix, Inc. and Battelle today announced they have extended their co-marketing partnership for the DosePro(R) needle-free drug delivery system through March 29, 2014. The partnership is focused on advancing out-licensing opportunities for DosePro, with a focus on co-marketing the technology to potential biopharmaceutical and government clients.

William Dunlevy, Vice President and General Manager, Process and Product Development at Battelle, said, “Over the course of the past year, we have worked closely with Zogenix to develop and implement a focused co-marketing campaign that highlights key attributes of the DosePro needle-free delivery system. We have received positive feedback regarding our study of DosePro delivery of a monoclonal antibody and our self-injection survey of patients with rheumatoid arthritis. These findings clearly demonstrate the benefits and capabilities of the DosePro system. This has driven strong interest in the DosePro technology from our clients, particularly in the delivery of highly viscous formulations and biologics.”

The campaign highlights a study by Battelle that demonstrates the ability of the DosePro system to effectively deliver a monoclonal antibody therapeutic, AbbVie’s Humira(R) (adalimumab). The in vitro study showed that DosePro can deliver Humira without incremental risk to protein denaturation and equivalent biological integrity as compared to delivery by pre-filled syringe.

John Turanin, Vice President and General Manager, DosePro Technology, at Zogenix, commented, “In the three years since its launch, we have produced more than 2 million commercial units of our first commercial DosePro product, SUMAVEL(R) DosePro(R). The introduction of a needle-free delivery option has reinvigorated growth of injectable sumatriptan, including from patients that were previously not interested due to needle-phobia and/or the complexity of delivery. We are pleased to provide an enhanced needle-free option for these patients and look forward to continue working with Battelle to introduce the benefits of the DosePro system to potential partners in the biopharmaceutical and government sectors.”

 

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE